Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Early methionine availability attenuates T cell exhaustion.

Nature immunology·2026
Same author

Dual targeting of oncogenic microtubules and mitochondria in PDAC.

Oncoscience·2026
Same author

Neoadjuvant Chemoradiation Versus Chemotherapy for Esophageal Cancer: A Histology-Stratified Update Meta-Analysis of Randomized Controlled Trials.

Annals of surgical oncology·2026
Same author

Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanoma.

Journal of cancer research and clinical oncology·2025
Same author

Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour efficacy in pancreatic cancer.

British journal of pharmacology·2025
Same author

Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma.

Current oncology (Toronto, Ont.)·2025

Related Experiment Video

Updated: Jun 18, 2026

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
06:45

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System

Published on: July 2, 2020

Targeted hyperthermia using metal nanoparticles.

Paul Cherukuri1, Evan S Glazer, Steven A Curley

  • 1The Department of Surgical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

Advanced Drug Delivery Reviews
|November 14, 2009
PubMed
Summary
This summary is machine-generated.

Metal nanoparticles offer a promising approach to cancer hyperthermia treatment by selectively heating malignant cells. This review explores their role, particularly gold nanoparticles, and compares them to radiofrequency ablation.

More Related Videos

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Related Experiment Videos

Last Updated: Jun 18, 2026

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
06:45

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System

Published on: July 2, 2020

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

Area of Science:

  • Oncology
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Hyperthermia has a long history in cancer treatment, but selective tumor heating remains a challenge.
  • Metal nanoparticles are being investigated for targeted hyperthermia, inducing cytotoxicity in malignant cells.
  • Near-infrared radiation and radiofrequency fields are key energy sources for nanoparticle-mediated hyperthermia.

Purpose of the Study:

  • To review the emerging applications of nanoparticles, specifically gold nanoparticles, in cancer hyperthermia.
  • To discuss the mechanisms of nanoparticle-mediated hyperthermic cytotoxicity.
  • To compare nanoparticle-mediated hyperthermia with traditional radiofrequency ablation techniques.

Main Methods:

  • Review of pre-clinical and early clinical trial data on nanoparticle hyperthermia.
  • Analysis of the physical principles behind near-infrared and radiofrequency energy application.
  • Comparative analysis of nanoparticle-mediated cytotoxicity and radiofrequency ablation.

Main Results:

  • Metal nanoparticles demonstrate efficacy in inducing hyperthermic cytotoxicity in pre-clinical and early clinical settings.
  • Gold nanoparticles show particular promise due to their unique properties for hyperthermia.
  • Similarities exist between radiofrequency ablation and nanoparticle-mediated hyperthermia in terms of cellular effects.

Conclusions:

  • Nanoparticle-mediated hyperthermia represents an evolving and promising strategy for targeted cancer treatment.
  • Further research and clinical trials are warranted to optimize nanoparticle-based hyperthermia therapies.
  • Nanoparticle hyperthermia may offer an alternative or complementary approach to existing thermal ablation methods.